Flow Cytometry and Targeted Immune Transcriptomics Identify Distinct Profiles in Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors with or Without Interferon-Alpha
AuthID
P-00R-K2Y
P-00R-K2Y